Chief Financial Officer Robin Kramer explained how the deal not only provides two marketed products, but a team with nephrology expertise that will be valuable as Biogen prepares to launch felzartamab ...
Scientists have uncovered an important new link between the brain and immune system after stroke, which could lead to ...
Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, ...
The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, 2026, in Immunity ...
Immunoglobulin A (IgA) nephropathy results from the accumulation of IgA-containing immune complexes (IgA-ICs) and aberrant ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that data from the Phase 3 study of vilobelimab ...
The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, ...
Explore how human-relevant tumor models like 3D cultures, organoids, organ-on-chip platforms, and the 3MIC system are ...
Biogen said Tuesday that it would buy Apellis Pharmaceuticals for an upfront payment of around $5.6 billion, expanding its ...
Morning Overview on MSN
New BA.3.2 COVID variant spreads in US with immune-evasion mutations
A SARS-CoV-2 subvariant called BA.3.2, carrying a significant genomic deletion and mutations linked to immune evasion, has ...
A new deep-brain BCI from Tsinghua University uses the lateral ventricles to record neural signals. This "lantern" electrode ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results